Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Green

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Seminars in Vascular Surgery|September 14, 2002
New training paradigms: The three-plus-three programRichard M Green
Journal of the American College of Surgeons|January 22, 2002
Patient selection for endovascular abdominal aortic aneurysm repairRichard M Green
Vascular|May 7, 2004
What changes are needed to keep vascular surgery alive and vigorous?Richard M Green
Current Problems in Surgery|January 30, 2003
The role of prophylactic anticoagulation in the surgical patientRichard M Green
Hepatology (Baltimore, Md.)|June 28, 2003
NASH--hepatic metabolism and not simply the metabolic syndromeRichard M Green
Journal of Vascular Surgery|September 1, 2004
A live dog is better than a dead lionRichard M Green
Veterinary Clinical Pathology|May 22, 2010
Tyrosine-derived 4-hydroxyphenylpyruvate reacts with ketone test fields of 3 commercially available urine dipsticksJames Cartwright, Richard M Green
Hepatology (Baltimore, Md.)|July 8, 2020
Telomeres, p53, Hepatocyte Nuclear Factor 4α, and Liver DiseaseMark Antkowiak, Richard M Green
Journal of Vascular Surgery|December 19, 2003
Five-year results of a merger between vascular surgeons and interventional radiologists in a university medical centerRichard M Green, David Waldman,
Hepatology (Baltimore, Md.)|July 28, 2017
Beyond Farnesoid X receptor to target new therapies for NAFLDXiaoying Liu, Richard M Green
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Seminars in Vascular Surgery|September 14, 2002
New training paradigms: The three-plus-three programRichard M Green
Journal of the American College of Surgeons|January 22, 2002
Patient selection for endovascular abdominal aortic aneurysm repairRichard M Green
Vascular|May 7, 2004
What changes are needed to keep vascular surgery alive and vigorous?Richard M Green
Current Problems in Surgery|January 30, 2003
The role of prophylactic anticoagulation in the surgical patientRichard M Green
Hepatology (Baltimore, Md.)|June 28, 2003
NASH--hepatic metabolism and not simply the metabolic syndromeRichard M Green
Journal of Vascular Surgery|September 1, 2004
A live dog is better than a dead lionRichard M Green
Veterinary Clinical Pathology|May 22, 2010
Tyrosine-derived 4-hydroxyphenylpyruvate reacts with ketone test fields of 3 commercially available urine dipsticksJames Cartwright, Richard M Green
Hepatology (Baltimore, Md.)|July 8, 2020
Telomeres, p53, Hepatocyte Nuclear Factor 4α, and Liver DiseaseMark Antkowiak, Richard M Green
Journal of Vascular Surgery|December 19, 2003
Five-year results of a merger between vascular surgeons and interventional radiologists in a university medical centerRichard M Green, David Waldman,
Hepatology (Baltimore, Md.)|July 28, 2017
Beyond Farnesoid X receptor to target new therapies for NAFLDXiaoying Liu, Richard M Green
Pageof 14